Addus HomeCare Corp (ADUS) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Addus HomeCare Corporation operates as a multi-state provider of in-home services across three segments: Personal Care (non-medical assistance), Hospice (end-of-life care), and Home Health (skilled medical services). The company serves approximately 70,000 discrete individuals across 22 states through 214 offices.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | YTD 2024 (6 Months) | Q2 2023 (3 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Net Service Revenues | $286.9 million | $567.7 million | $260.0 million | $511.6 million |
| Gross Profit | $93.2 million (32.5% margin) | $181.3 million (31.9% margin) | $82.3 million (31.7% margin) | $160.7 million (31.4% margin) |
| Operating Income | $26.2 million (9.1% margin) | $49.8 million (8.8% margin) | $21.5 million (8.3% margin) | $40.1 million (7.7% margin) |
| Net Income | $18.1 million | $33.9 million | $14.9 million | $27.5 million |
| Diluted EPS | $1.10 | $2.06 | $0.91 | $1.69 |
| Cash and Equivalents | $173.3 million (as of June 30, 2024) | |||
| Long-Term Debt | $0 (Revolving credit facility fully repaid) | |||
| Operating Cash Flow (YTD) | $57.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Net service revenues increased 10.4% in Q2 and 11.0% YTD compared to 2023. Growth was driven by rate increases in the Personal Care segment (particularly in Illinois) and the full-year impact of the Tennessee Quality Care acquisition in Hospice and Home Health segments.
- Profitability Expansion: Gross margin improved to 32.5% in Q2 2024 from 31.7% in Q2 2023. Operating income grew 21.6% in Q2 and 24.1% YTD, outpacing revenue growth due to operational efficiencies and favorable mix.
- Balance Sheet Transformation: The company completed a public offering in June 2024, raising approximately $175.6 million in net proceeds. These funds were used to fully repay the $126.4 million outstanding on its revolving credit facility, resulting in zero long-term debt as of June 30, 2024.
- Divestiture: The company entered an agreement to sell its New York personal care operations for up to $23.0 million. An initial payment of $4.6 million was received in Q2. The assets are classified as held for sale.
Guidance, Outlook, and Risks
- Strategic Acquisitions: Addus entered a definitive agreement to acquire the personal care operations of Gentiva for approximately $350.0 million. The deal is expected to close following regulatory approvals and will be funded by the credit facility and remaining proceeds from the public offering.
- Reimbursement Environment: The company benefits from rate increases in Illinois effective January 2024 ($28.07/hour) and planned for 2025 ($29.63/hour). However, it faces uncertainty regarding the New York Consumer Directed Personal Assistance Program (CDPAP), which is transitioning to a single statewide fiscal intermediary by April 2025, prompting the New York divestiture.
- Regulatory Risks: The company monitors the CMS "Ensuring Access to Medicaid Services" final rule, which includes an "80/20" payment adequacy requirement for direct care worker compensation, with compliance required by mid-2030. Additionally, Medicare sequestration cuts remain in effect through 2032, with potential additional reductions delayed until 2025.
- Liquidity: With the credit facility repaid, the company has approximately $504.4 million in capacity available for future borrowings or acquisitions.
Investor Verification Checklist
- Gentiva Acquisition Status: Verify the timeline for regulatory approvals and the final closing date for the $350 million Gentiva acquisition.
- New York Divestiture Completion: Monitor the progress of the New York asset sale and the finalization of the $23 million purchase price.
- Illinois Rate Sustainability: Confirm the implementation of the 2025 rate increase to $29.63/hour and assess the risk of future reimbursement stagnation.
- CDPAP Transition Impact: Evaluate the specific operational and financial impact of the New York CDPAP program changes on remaining operations.
- Debt Covenant Compliance: While currently debt-free, verify the company's ability to maintain leverage ratios if it re-borrows to fund the Gentiva acquisition.